Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
International Journal of Molecular Sciences
|
July 9, 2022
Interleukin 15 in Cell-Based Cancer Immunotherapy
Yang Zhou, Tiffany Husman, Xinjian Cen, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
August 15, 2025
Cystic fibrosis airway epithelial cells have an exaggerated response to hypoxia that is partially reversible through transmembrane receptor modulation
Elsa Brunet-Ratnasingham, Tasha Tsao, Rashmi P Mohanty, et al.
Cancers
|
May 14, 2022
Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy
Yang Zhou, Miao Li, Kuangyi Zhou, et al.
Frontiers in Immunology
|
October 25, 2021
Lung Allograft Epithelium DNA Methylation Age Is Associated With Graft Chronologic Age and Primary Graft Dysfunction
Daniel T Dugger, Daniel R Calabrese, Ying Gao, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Site-specific genome engineering of primary human natural killer cells for programmable anti-tumor function
Vincent Allain, Allison G Rothrock, Pierre-Louis Bernard, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 25, 2023
<i>MICB</i> Genomic Variant Is Associated with NKG2D-mediated Acute Lung Injury and Death
Oscar A Aguilar, Anita E Qualls, Maria D R Gonzalez-Hinojosa, et al.
JCI Insight
|
October 3, 2023
CCR5 drives NK cell-associated airway damage in pulmonary ischemia-reperfusion injury
Jesse Santos, Ping Wang, Avishai Shemesh, et al.
The European Respiratory Journal
|
August 27, 2024
CD94<sup>+</sup> natural killer cells potentiate pulmonary ischaemia-reperfusion injury
Tasha Tsao, Longhui Qiu, Reena Bharti, et al.
Cell Reports. Medicine
|
November 29, 2021
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
Yan-Ruide Li, Yang Zhou, Yu Jeong Kim, et al.
JCI Insight
|
November 8, 2022
NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes
Daniel R Calabrese, Tasha Tsao, Mélia Magnen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
International Journal of Molecular Sciences
|
July 9, 2022
Interleukin 15 in Cell-Based Cancer Immunotherapy
Yang Zhou, Tiffany Husman, Xinjian Cen, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
August 15, 2025
Cystic fibrosis airway epithelial cells have an exaggerated response to hypoxia that is partially reversible through transmembrane receptor modulation
Elsa Brunet-Ratnasingham, Tasha Tsao, Rashmi P Mohanty, et al.
Cancers
|
May 14, 2022
Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy
Yang Zhou, Miao Li, Kuangyi Zhou, et al.
Frontiers in Immunology
|
October 25, 2021
Lung Allograft Epithelium DNA Methylation Age Is Associated With Graft Chronologic Age and Primary Graft Dysfunction
Daniel T Dugger, Daniel R Calabrese, Ying Gao, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Site-specific genome engineering of primary human natural killer cells for programmable anti-tumor function
Vincent Allain, Allison G Rothrock, Pierre-Louis Bernard, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 25, 2023
<i>MICB</i> Genomic Variant Is Associated with NKG2D-mediated Acute Lung Injury and Death
Oscar A Aguilar, Anita E Qualls, Maria D R Gonzalez-Hinojosa, et al.
JCI Insight
|
October 3, 2023
CCR5 drives NK cell-associated airway damage in pulmonary ischemia-reperfusion injury
Jesse Santos, Ping Wang, Avishai Shemesh, et al.
The European Respiratory Journal
|
August 27, 2024
CD94<sup>+</sup> natural killer cells potentiate pulmonary ischaemia-reperfusion injury
Tasha Tsao, Longhui Qiu, Reena Bharti, et al.
Cell Reports. Medicine
|
November 29, 2021
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
Yan-Ruide Li, Yang Zhou, Yu Jeong Kim, et al.
JCI Insight
|
November 8, 2022
NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes
Daniel R Calabrese, Tasha Tsao, Mélia Magnen, et al.
Page
of 2